Skip to main content
Signal8

Cheruvu Pavan

SEC insider (Form 3/4/5 filer). CIK 0001731741. Director at Retension Pharmaceuticals, Inc. (RTSN) and 1 other issuer. 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 13, 2026. Located in FALLS CHURCH, VA.

Companies Cheruvu Pavan has filed insider reports for

  • Retension Pharmaceuticals, Inc. (RTSN): Director
  • Amanat Acquisition Corp. (AMAN): Director, Officer, Chief Executive Officer
Cheruvu Pavan profile photo

Cheruvu Pavan

CIK: 0001731741

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Retension Pharmaceuticals, Inc. logo
RTSN

Retension Pharmaceuticals, Inc.

Director
Amanat Acquisition Corp. logo
AMAN

Amanat Acquisition Corp.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 13, 2026
    Award

    Stock Option (right to buy)

    Direct
    5.6K shares-

1-1 of 1